The Russian pharmaceutical company Geropharm has sent its first insulin shipment to Venezuela. Insulin is a crucial hormone for people suffering from type 1 diabetes mellitus and who cannot survive without its administration. US sanctions against Venezuela have closed the door to access to traditional suppliers causing incredible pain to the Venezuelan population

In this sense, Geropharm becomes the only provider of this vital drug in this country. In the near future, genetically modified insulin of short and medium duration in bottles will be available to patients across the country, according to the Russian Ministry of Industry and Commerce.